| 000 | 01144 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516060604.0 | ||
| 264 | 0 | _c20120215 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1532-1681 | ||
| 024 | 7 |
_a10.1016/j.blre.2011.09.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoychowdhury, Sameek | |
| 245 | 0 | 0 |
_aManaging resistance in chronic myeloid leukemia. _h[electronic resource] |
| 260 |
_bBlood reviews _cNov 2011 |
||
| 300 |
_a279-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 700 | 1 | _aTalpaz, Moshe | |
| 773 | 0 |
_tBlood reviews _gvol. 25 _gno. 6 _gp. 279-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.blre.2011.09.001 _zAvailable from publisher's website |
| 999 |
_c21216418 _d21216418 |
||